Literature DB >> 10435618

Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.

V A Soldatenkov1, A Albor, B K Patel, R Dreszer, A Dritschilo, V Notario.   

Abstract

Ewing's sarcoma (EWS) cells accumulate elevated steady-state levels of poly (ADP-ribose) polymerase (PARP) mRNA and protein. To understand the molecular mechanisms underlying PARP upregulation, we cloned and analysed the 5'-flanking region of the PARP gene from EWS cells. Nucleotide sequence analysis demonstrated no variations in the PARP promoter region in EWS cells. The PARP promoter encompasses multiple binding motifs for the ETS transcription factor. We have also observed that there is a coordinated up-regulation of the expression of both PARP and ETS1, relative to cells of other human tumor types expressing lower levels of PARP. Transient co-expression of ETS1 in EWS cells resulted in a strong enhancement of PARP-promoter activity. The participation of ETS in the regulation of PARP gene expression was further demonstrated in EWS cells stably transfected with Ets1 antisense cDNA constructs. Antisense-mediated down-regulation of endogenous ETS1 resulted in the inhibition of PARP expression in EWS cells, and sensitized these cells to ionizing radiation. These data provide support for ETS regulation of PARP expression levels, and implicate ETS transcription factors in the radiation response of EWS cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435618     DOI: 10.1038/sj.onc.1202778

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

Review 1.  The ETS family of oncogenic transcription factors in solid tumours.

Authors:  Gina M Sizemore; Jason R Pitarresi; Subhasree Balakrishnan; Michael C Ostrowski
Journal:  Nat Rev Cancer       Date:  2017-04-28       Impact factor: 60.716

Review 2.  PARP and PARG inhibitors--new therapeutic targets in cancer treatment.

Authors:  Nilufer Jasmine Selimah Fauzee; Juan Pan; Ya-lan Wang
Journal:  Pathol Oncol Res       Date:  2010-04-12       Impact factor: 3.201

Review 3.  Coordination of DNA single strand break repair.

Authors:  Rachel Abbotts; David M Wilson
Journal:  Free Radic Biol Med       Date:  2016-11-24       Impact factor: 7.376

4.  Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV).

Authors:  Marcela Kazue Hassumi-Fukasawa; Fabiana Alves Miranda-Camargo; Bruna Riedo Zanetti; Denise Faria Galano; Alfredo Ribeiro-Silva; Edson Garcia Soares
Journal:  Pathol Oncol Res       Date:  2012-03-28       Impact factor: 3.201

5.  Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types.

Authors:  Valeria Ossovskaya; Ingrid Chou Koo; Eric P Kaldjian; Christopher Alvares; Barry M Sherman
Journal:  Genes Cancer       Date:  2010-08

6.  PDEF is a negative regulator of colon cancer cell growth and migration.

Authors:  Omar Moussa; David P Turner; Ron J Feldman; Victor I Sementchenko; Brent D McCarragher; Mohamed M Desouki; Mostafa Fraig; Dennis K Watson
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

7.  Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer.

Authors:  Francine Durocher; Yvan Labrie; Geneviève Ouellette; Jacques Simard
Journal:  J Hum Genet       Date:  2007-10-18       Impact factor: 3.172

8.  CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.

Authors:  Lisa Kashima; Masashi Idogawa; Hiroaki Mita; Miki Shitashige; Tesshi Yamada; Kazuhiro Ogi; Hiromu Suzuki; Minoru Toyota; Hiroyoshi Ariga; Yasushi Sasaki; Takashi Tokino
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

Review 9.  Advances in therapy for pediatric sarcomas.

Authors:  Aaron Weiss; Jonathan Gill; John Goldberg; Joanne Lagmay; Holly Spraker-Perlman; Rajkumar Venkatramani; Damon Reed
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

Review 10.  Prospects and challenges for the development of new therapies for Ewing sarcoma.

Authors:  Patrick J Grohar; Lee J Helman
Journal:  Pharmacol Ther       Date:  2012-10-18       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.